Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixto - Loibl, Sibylle; Weber, K. E.; Timms, K. M.; Elkin, E. P.; Hahnen, K.; Fasching, P. A; Lederer, B.; Denkert, A.; Schneeweiss, Andreas; Braun, S; Salat, C. T.; Rezai, M.; et al. (Annals of oncology, 2018)